Search

Displaying all 5 results
  1. Pathway

    Chlorpromazine - Serotonin Antagonist Action Pathway

    smpdb.ca/view/SMP0126487
    Drug action

    to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1 … pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate

    Drugs: Pyridoxal phosphate · Tryptophan · Sapropterin · Chlorpromazine · Calcium · Iron +1 more
    Enzymes: Sodium-dependent serotonin transporter
  2. Pathway

    Acepromazine - Serotonin Antagonist Action Pathway

    smpdb.ca/view/SMP0126586
    Drug action

    gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors … - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia

    Drugs: Pyridoxal phosphate · Tryptophan · Sapropterin · Calcium · Iron · Acepromazine +1 more
    Enzymes: Sodium-dependent serotonin transporter
  3. Pathway

    Pipotiazine Serotonin antagonist Action Pathway

    smpdb.ca/view/SMP0126800
    Drug action

    gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors … - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia

    Drugs: Pyridoxal phosphate · Tryptophan · Sapropterin · Calcium · Iron · Pipotiazine +1 more
    Enzymes: Sodium-dependent serotonin transporter
  4. Pathway

    Duloxetine (SNRI) - Norepinephrine Reuptake Inhibiton

    smpdb.ca/view/SMP0125000
    Drug action

    Duloxetine has no significant activity for muscarinic, cholinergic, alpha2-adrenergic, or H1 histaminergic receptors. … It blocks both sodium dependent serotonin and sodium dependent norepinephrine transporters from removing serotonin and norepinephrine respectively from the synaptic cleft.

    Drugs: Pyridoxal phosphate · Ascorbic acid · Tyrosine · Norepinephrine · Duloxetine · Dopamine +4 more
  5. Pathway

    Duloxetine SNRI - Dopamine Norepinephrine Inhibition Action Pathway

    smpdb.ca/view/SMP0126450
    Drug action

    Duloxetine has no significant activity for muscarinic, cholinergic, alpha2-adrenergic, or H1 histaminergic receptors … It blocks both sodium dependent serotonin and sodium dependent norepinephrine transporters from removing serotonin and norepinephrine respectively from the synaptic cleft.

    Drugs: Pyridoxal phosphate · Ascorbic acid · Tyrosine · ATP · Norepinephrine · Duloxetine +8 more